While the American car market was booming in the '50s, independent carmakers were struggling in the face of the financial ...

Everything we’ve done in 2025 has been thoughtful, intentional and focused on elevating our Safety & Racing brands,” said Matthew Stevenson, President & CEO, Holley Performance Brands. “We’ve aligned ...

A 14,000-mile 1999 Camaro SS with substantial performance modifications is now listed for sale ahead of its Bring a Trailer auction.

EXZOLT™ CATTLE-CA1 is the first in its class and the only product conditionally approved for both the prevention and treatment of New World screwworm and treatment and control of cattle fever ...

Merck Animal Health’s Exzolt Cattle-CA1 receives US FDA conditional approval for prevention and treatment of New World screwworm larvae: Rahway, New Jersey Saturday, December 6, ...

The ALS Association is pleased to announce the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support early-phase trials that generate ...

EXZOLT™ CATTLE-CA1 is the first in its class and the only product conditionally approved for both the prevention and ...

Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the U.S. military, ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA , today announced the U.S. Food and Drug Administration (FDA ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...